174 related articles for article (PubMed ID: 9702843)
1. A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection.
Zhou H; Goldman M; Wu J; Woestenborghs R; Hassell AE; Lee P; Baruch A; Pesco-Koplowitz L; Borum J; Wheat LJ
J Clin Pharmacol; 1998 Jul; 38(7):593-602. PubMed ID: 9702843
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intravenous itraconazole followed by itraconazole oral solution in patients with human immunodeficiency virus infection.
Zhao Q; Zhou H; Pesco-Koplowitz L
J Clin Pharmacol; 2001 Dec; 41(12):1319-28. PubMed ID: 11762559
[TBL] [Abstract][Full Text] [Related]
3. Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.
Vandewoude K; Vogelaers D; Decruyenaere J; Jaqmin P; De Beule K; Van Peer A; Woestenborghs R; Groen K; Colardyn F
Antimicrob Agents Chemother; 1997 Dec; 41(12):2714-8. PubMed ID: 9420044
[TBL] [Abstract][Full Text] [Related]
4. Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers.
Barone JA; Moskovitz BL; Guarnieri J; Hassell AE; Colaizzi JL; Bierman RH; Jessen L
Pharmacotherapy; 1998; 18(2):295-301. PubMed ID: 9545149
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy.
Boogaerts MA; Maertens J; Van Der Geest R; Bosly A; Michaux JM; Van Hoof A; Cleeren M; Wostenborghs R; De Beule K
Antimicrob Agents Chemother; 2001 Mar; 45(3):981-5. PubMed ID: 11181397
[TBL] [Abstract][Full Text] [Related]
6. Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents.
Abdel-Rahman SM; Jacobs RF; Massarella J; Kauffman RE; Bradley JS; Kimko HC; Kearns GL; Shalayda K; Curtin C; Maldonado SD; Blumer JL
Antimicrob Agents Chemother; 2007 Aug; 51(8):2668-73. PubMed ID: 17517842
[TBL] [Abstract][Full Text] [Related]
7. Influence of grapefruit juice on the systemic availability of itraconazole oral solution in healthy adult volunteers.
Gubbins PO; McConnell SA; Gurley BJ; Fincher TK; Franks AM; Williams DK; Penzak SR; Saccente M
Pharmacotherapy; 2004 Apr; 24(4):460-7. PubMed ID: 15098799
[TBL] [Abstract][Full Text] [Related]
8. Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules.
Glasmacher A; Hahn C; Molitor E; Marklein G; Sauerbruch T; Schmidt-Wolf IG
Mycoses; 1999; 42(11-12):591-600. PubMed ID: 10680434
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients.
Mohr JF; Finkel KW; Rex JH; Rodriguez JR; Leitz GJ; Ostrosky-Zeichner L
Antimicrob Agents Chemother; 2004 Aug; 48(8):3151-3. PubMed ID: 15273137
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
[TBL] [Abstract][Full Text] [Related]
11. Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers.
Barone JA; Moskovitz BL; Guarnieri J; Hassell AE; Colaizzi JL; Bierman RH; Jessen L
Antimicrob Agents Chemother; 1998 Jul; 42(7):1862-5. PubMed ID: 9661037
[TBL] [Abstract][Full Text] [Related]
12. Linking the concentrations of itraconazole and 2-hydroxypropyl-β-cyclodextrin in human intestinal fluids after oral intake of Sporanox
Berben P; Stappaerts J; Vink MJA; Domínguez-Vega E; Somsen GW; Brouwers J; Augustijns P
Eur J Pharm Biopharm; 2018 Nov; 132():231-236. PubMed ID: 29959034
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis.
Reynes J; Bazin C; Ajana F; Datry A; Le Moing JP; Chwetzoff E; Levron JC
Antimicrob Agents Chemother; 1997 Nov; 41(11):2554-8. PubMed ID: 9371367
[TBL] [Abstract][Full Text] [Related]
14. Itraconazole disposition after single oral and intravenous and multiple oral dosing in healthy cats.
Boothe DM; Herring I; Calvin J; Way N; Dvorak J
Am J Vet Res; 1997 Aug; 58(8):872-7. PubMed ID: 9256973
[TBL] [Abstract][Full Text] [Related]
15. Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis.
Caillot D
Acta Haematol; 2003; 109(3):111-8. PubMed ID: 12714819
[TBL] [Abstract][Full Text] [Related]
16. Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis.
Groll AH; Wood L; Roden M; Mickiene D; Chiou CC; Townley E; Dad L; Piscitelli SC; Walsh TJ
Antimicrob Agents Chemother; 2002 Aug; 46(8):2554-63. PubMed ID: 12121932
[TBL] [Abstract][Full Text] [Related]
17. Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis.
Cartledge JD; Midgely J; Gazzard BG
J Clin Pathol; 1997 Jun; 50(6):477-80. PubMed ID: 9378812
[TBL] [Abstract][Full Text] [Related]
18. Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.
de Repentigny L; Ratelle J; Leclerc JM; Cornu G; Sokal EM; Jacqmin P; De Beule K
Antimicrob Agents Chemother; 1998 Feb; 42(2):404-8. PubMed ID: 9527794
[TBL] [Abstract][Full Text] [Related]
19. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation.
Mouton JW; van Peer A; de Beule K; Van Vliet A; Donnelly JP; Soons PA
Antimicrob Agents Chemother; 2006 Dec; 50(12):4096-102. PubMed ID: 16982783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
